Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody in Patients with Microsatellite Stable Colorectal Cancer
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody in Patients with Microsatellite Stable Colorectal Cancer
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology Annual Meeting
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology Annual Meeting
Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® for Follicular Lymphoma in Argentina and Mexico
Incyte Announces the European Commission Approval of Zynyz® for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal
Incyte Announces Positive CHMP Opinion for Zynyz® for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal
Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring
